N-Oleoylethanolamine, PPAR-alpha agonist

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The TRPV1 (Transient Receptor Potential Vanilloid 1) and TRPV2 proteins are non-selective cation channels part of the TRP channel family where they mediate influx of calcium and sodium ions. TRPV1 also referred as the capsaicin receptor has a molecular mass of 95 kDa and TRPV2 displays similar mass traits. Both proteins are widely expressed in the central and peripheral nervous systems as well as in non-neuronal tissues like the skin and digestive tract. PPAR alpha (Peroxisome Proliferator-Activated Receptor Alpha) is a nuclear receptor with molecular functioning involving the modulation of gene expression key for lipid metabolism and is abundantly located in liver heart kidney and muscle tissues. The Cannabinoid Receptor I (CB1) mostly found in the central nervous system binds to endocannabinoids and functionally impacts neurotransmitter release.

Biological function summary

TRPV1 and TRPV2 are responsive to temperature changes chemical stimuli and mechanical stress acting as sensors for pain and inflammation signals. They often operate as homomeric or heteromeric complexes contributing to heat and pain perception. PPAR alpha functions as a transcription factor regulating genes essential for fatty acid oxidation and energy homeostasis. CB1 functioning within the endocannabinoid system influences processes like appetite pain modulation and memory. These targets are involved in important biological processes interacting with endogenous ligands like oleoylethanolamide n-oleoylethanolamine and PPAR alpha agonist molecules which regulate their activity.

Pathways

TRPV1 and TRPV2 proteins integrate within the pain and inflammatory response pathways. They work alongside related proteins modulating nociceptive signaling. PPAR alpha participates in the lipid metabolism pathway primarily interacting with enzymes involved in fatty acid oxidation. Its agonistic interactions influence metabolic rate together with alpha agonists impacting the energy balance in organisms. CB1 is central to the endocannabinoid signaling pathway interacting with relevant lipids like oleoylethanolamide and proteins linked to neuromodulatory functions influencing neural activity.

TRPV1 has associations with chronic pain syndromes and inflammatory conditions as its overexpression leads to heightened pain sensitivity. TRPV2 mutations link with cardiomyopathy implicating its role in cardiac stress responses. PPAR alpha's dysfunction connects to metabolic conditions like hyperlipidemia and atherosclerosis where impaired lipid regulation results in systemic metabolic disturbances. CB1 interactions relate to neurological disorders and obesity connecting to pathways that regulate mood and energy intake. These proteins by connecting therapeutic targets like n-oleoylethanolamine play roles in disease modulation offering potential intervention points.